Vertex Pharmaceuticals Inc. (VRTX) Up on Positive Drug Trials

Shares of Cambridge, Massachusetts-based Vertex Pharmaceuticals (VRTX) were up sharply on Tuesday, amid a broadly lower market on Wall Street. Vertex’s stock was up 40.41%, rising $26.92 to close at $93.53 per share, on volume of 25,236,837 shares. The company announced positive results for a drug it has formulated in treating cystic fibrosis. The successful Read the full article... Read the rest of Vertex Pharmaceuticals Inc. (VRTX) Up on Positive Drug Trials at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.